New funded grant by UMS member: Professor Toby Prevost
2014-2017 CLEOPATRA: A multicentre phase III randomised controlled single masked clinical trial to test the clinical efficacy of LightMasks at preventing dark adaptation in the treatment of early diabetic macular oedema.
PI: S. Sivaprasad (KCH and Moorfields). NIHR EME 11_30_02 £1.1M. (42 months).